Phase Holographic Imaging PHI AB

Equities

PHI

SE0005504636

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-01-30 pm EST			5-day change	1st Jan Change
6.46 ^SEK	-4.44%		-.--%	+8.39%

Jun. 13	Sweden-based PHI Plots Iberian Expansion with Distribution Subcontract Deal	MT
Jun. 13	Phase Holographic Imaging Phi AB Expands to Spanish and Portuguese Markets Through Altium's New Subcontract with Paralab	CI

PHI to BioStock: "It's the right moment to capitalize on regenerative medicine momentum."

May 23, 2024 at 03:22 am EDT

Medtech company Phase Holographic Imaging recently secured a loan facility of SEK 7 million. The company has decided to draw the first tranche from that loan-- SEK 4.5 million. In a press release, CEO Patrik Eschricht stated that this provides an opportunity to act on the company's current momentum. BioStock talked to Eschricht to learn more.

Read the full interview with Patrik Eschricht at biostock.se:

https://www.biostock.se/en/2024/05/phi-its-the-right-moment-to-capitalize-on-regenerative-medicine-momentum/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

https://news.cision.com/phase-holographic/r/phi-to-biostock---it-s-the-right-moment-to-capitalize-on-regenerative-medicine-momentum-,c3986648

Latest news about Phase Holographic Imaging PHI AB

Sweden-based PHI Plots Iberian Expansion with Distribution Subcontract Deal	Jun. 13	MT
Phase Holographic Imaging Phi AB Expands to Spanish and Portuguese Markets Through Altium's New Subcontract with Paralab	Jun. 13	CI
Phase Holographic Imaging Obtains SEK7 Million Loan Agreement	May. 17	MT
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 27	CI
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member	Mar. 14	CI
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine	Mar. 11	CI
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024	Jan. 30	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 21	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-20	CI
European Patent Office Intends to Grant Phase Holographic Imaging AB Patent on Synthetic Antibodies	23-07-04	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2023	23-06-26	CI
Phase Holographic Imaging Phi AB Elects Goran Dubravcic Elected as A New Member of the Board	23-05-09	CI
Altium Mitkap AG acquired a 11.8% stake in Phase Holographic Imaging PHI AB from Formue Nord A/S.	23-03-07	CI
PHI expands its global network to India	23-01-24	CI
Phase Holographic Imaging Announces Management Changes	23-01-17	CI
Phase Holographic Imaging PHI AB Announces Management Changes	23-01-17	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-21	CI
Phase Holographic Imaging Announces Opening A New Development Office in the U.S	22-11-21	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2022	22-09-29	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2022	22-06-29	CI
PHI Enters Biomanufacturing Partnership with Wake Forest Institute for Regenerative Medicine	22-04-06	CI
Phase Holographic Imaging Installs Holomonitor Fluorescence Now At Novo Nordisk A/S	22-03-30	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	22-03-21	CI
Phase Holographic Imaging Phi AB Announces Sales Results for the Three Months and Full Year Ended January 2022	22-03-15	CI
Phase Holographic Imaging PHI AB Moves to New Premises	22-03-10	CI

Chart Phase Holographic Imaging PHI AB

Duration

Period

More charts

Company Profile

Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Companyâs product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-25 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
PHASE HOLOGRAPHIC IMAGING PHI AB	+8.39%	16.06M
SARTORIUS AG	-26.26%	16.26B
QUIDELORTHO CORPORATION	-50.54%	2.44B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+25.26%	1.98B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-8.81%	1.52B
BIOTAGE AB	+28.12%	1.3B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-18.54%	937M
CONTEC MEDICAL SYSTEMS CO.,LTD	-32.14%	775M
REVENIO GROUP OYJ	-1.69%	760M
VAREX IMAGING CORPORATION	-26.54%	615M

Medical Diagnostic & Testing Equipment